IONIS PHARMACEUTICALS INC (IONS)
US4622221004 - Common Stock
ChartMill assigns a Buy % Consensus number of 81% to IONS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 62.22. This target is 71.25% above the current price.
IONS was analyzed by 31 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about IONS.
In the previous month the buy percentage consensus was at a similar level.
IONS was analyzed by 31 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-20 | Needham | Maintains | Buy -> Buy |
| 2024-11-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-07 | Needham | Reiterate | Buy -> Buy |
| 2024-11-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-09 | Guggenheim | Maintains | Buy -> Buy |
| 2024-09-26 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-26 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-08-02 | Guggenheim | Maintains | Buy -> Buy |
| 2024-08-02 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2024-08-02 | Needham | Reiterate | Buy -> Buy |
| 2024-08-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-02 | Goldman Sachs | Maintains | Sell -> Sell |
| 2024-07-24 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-07-23 | TD Cowen | Maintains | Buy -> Buy |
| 2024-07-23 | B of A Securities | Maintains | Buy -> Buy |
| 2024-07-22 | Needham | Reiterate | Buy -> Buy |
| 2024-07-16 | B of A Securities | Maintains | Buy -> Buy |
| 2024-07-16 | Jefferies | Upgrade | Underperform -> Buy |
| 2024-06-27 | Stifel | Maintains | Hold -> Hold |
| 2024-06-14 | Bernstein | Upgrade | Underperform -> Market Perform |
| 2024-06-03 | Needham | Reiterate | Buy -> Buy |
| 2024-05-08 | Needham | Reiterate | Buy -> Buy |
| 2024-05-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-04-10 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2024-04-09 | Needham | Reiterate | Buy -> Buy |
| 2024-04-09 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-02-26 | Oppenheimer | Reiterate | Outperform |
| 2024-02-22 | Needham | Reiterate | Buy -> Buy |
| 2024-02-22 | Piper Sandler | Maintains | Overweight -> Overweight |